Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Long-Term Investments: 2020

Historic Long-Term Investments for Tango Therapeutics (TNGX) over the last 1 years, with Dec 2020 value amounting to $166.8 million.

  • Tango Therapeutics' Long-Term Investments was N/A to $166.8 million in Q2 2021 from the same period last year, while for Jun 2021 it was $166.8 million, marking a year-over-year change of. This contributed to the annual value of $166.8 million for FY2020, which is N/A change from last year.
  • Latest data reveals that Tango Therapeutics reported Long-Term Investments of $166.8 million as of FY2020.
  • Tango Therapeutics' 5-year Long-Term Investments high stood at $166.8 million for FY2020, and its period low was $166.8 million during FY2020.
  • Over the past 1 years, Tango Therapeutics' median Long-Term Investments value was $166.8 million (recorded in 2020), while the average stood at $166.8 million.